Open Access

[Corrigendum] Constitutive activation of MAPK/ERK inhibits prostate cancer cell proliferation through upregulation of BRCA2

  • Authors:
    • Loredana Moro
    • Arnaldo A. Arbini
    • Ersilia Marra
    • Margherita Greco
  • View Affiliations

  • Published online on: April 14, 2016     https://doi.org/10.3892/ijo.2016.3487
  • Pages: 2722-2722
  • Copyright: © Moro et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Constitutive activation of MAPK/ERK inhibits prostate cancer cell proliferation through upregulation of BRCA2

LOREDANA MORO, ARNALDO A. ARBINI, ERSILIA MARRA and MARGHERITA GRECO

[Related article:] Int J Oncol 30: 217–224, 2007; DOI: 10.3892/ijo.30.1.217

After the publication of the article the authors noted the following errors in the assembling of the figures. In Fig. 3A the tubulin panel for PC-3 cells is incorrect. The correct panel is reported below. In Figs. 3B and 5B the panels are incorrect. The correct panels are shown below. These changes do not affect the interpretation of the data or conclusions of this work.

Related Articles

Journal Cover

June-2016
Volume 48 Issue 6

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Moro L, Arbini AA, Marra E and Greco M: [Corrigendum] Constitutive activation of MAPK/ERK inhibits prostate cancer cell proliferation through upregulation of BRCA2. Int J Oncol 48: 2722-2722, 2016
APA
Moro, L., Arbini, A.A., Marra, E., & Greco, M. (2016). [Corrigendum] Constitutive activation of MAPK/ERK inhibits prostate cancer cell proliferation through upregulation of BRCA2. International Journal of Oncology, 48, 2722-2722. https://doi.org/10.3892/ijo.2016.3487
MLA
Moro, L., Arbini, A. A., Marra, E., Greco, M."[Corrigendum] Constitutive activation of MAPK/ERK inhibits prostate cancer cell proliferation through upregulation of BRCA2". International Journal of Oncology 48.6 (2016): 2722-2722.
Chicago
Moro, L., Arbini, A. A., Marra, E., Greco, M."[Corrigendum] Constitutive activation of MAPK/ERK inhibits prostate cancer cell proliferation through upregulation of BRCA2". International Journal of Oncology 48, no. 6 (2016): 2722-2722. https://doi.org/10.3892/ijo.2016.3487